prohormone convertase 1

prohormone convertase 1. It is a crucial serine protease enzyme belonging to the proprotein convertase family, primarily expressed in neuroendocrine tissues. This enzyme is responsible for the proteolytic cleavage and activation of numerous precursor proteins, including proinsulin, proopiomelanocortin, and proglucagon, into their biologically active forms. Its activity is essential for proper endocrine function and glucose homeostasis, with mutations in its encoding gene linked to severe human disorders.

Function and mechanism of action

The primary function of prohormone convertase 1 is the endoproteolytic processing of prohormones and neuropeptide precursors within the regulated secretory pathway. It cleaves precursor proteins at specific paired basic amino acid residues, typically lysine-arginine or arginine-arginine motifs. This action occurs predominantly in the trans-Golgi network and within immature secretory granules, facilitating the maturation of peptides like proinsulin into insulin and C-peptide. The enzyme's activity is calcium-dependent and optimally functions in the acidic environment of secretory granules, a process regulated by interactions with helper proteins like 7B2. Its precise cleavage is critical for generating the correct repertoire of active hormones that regulate processes such as appetite, metabolism, and stress response.

Gene and protein structure

The gene encoding prohormone convertase 1, designated *PCSK1*, is located on chromosome 5 in humans, specifically at locus 5q15. The gene spans approximately 40 kilobases and consists of 14 exons. The translated protein is initially synthesized as an inactive zymogen known as pro-PC1. This precursor undergoes autocatalytic activation within the endoplasmic reticulum, cleaving its own prodomain to generate the active enzyme. Mature PC1 is a 753-amino acid protein featuring a catalytic domain with homology to bacterial subtilisin, a P-domain essential for stability and pH sensing, and a carboxy-terminal domain that may influence its cellular trafficking and compartmentalization. Several single-nucleotide polymorphisms within *PCSK1* have been identified and associated with phenotypic variation.

Clinical significance

Deficiencies or loss-of-function mutations in the *PCSK1* gene are the cause of a rare, severe autosomal recessive disorder. This condition is characterized by early-onset malabsorptive diarrhea, obesity, and multiple endocrine abnormalities, including hypogonadotropic hypogonadism and impaired glucose tolerance. The pathophysiology stems from the failure to process critical prohormones like proinsulin, proglucagon, and pro-GHRH. Furthermore, common genetic variants in *PCSK1* have been associated in genome-wide association studies with an increased risk of obesity, type 2 diabetes, and coronary artery disease in the general population. Research into PC1 inhibitors is also being explored for potential therapeutic applications in conditions like prostate cancer.

Related enzymes and family

Prohormone convertase 1 is a founding member of the mammalian proprotein convertase family, which includes nine subtilisin-like serine proteases. Its closest homolog is prohormone convertase 2, with which it shares overlapping substrate specificity in neuroendocrine tissues, such as the processing of proopiomelanocortin in the pituitary gland. Other key family members include furin, which is ubiquitously expressed and processes precursors in the constitutive secretory pathway, and PACE4. The family is evolutionarily related to the yeast protease kexin, which processes the alpha-mating factor precursor. Each convertase has distinct, though sometimes overlapping, tissue expression patterns, intracellular localization, and substrate preferences, enabling the precise proteolytic regulation of diverse biological processes.

History and discovery

The discovery of prohormone convertase 1 emerged from the quest to identify the mammalian enzymes responsible for prohormone processing, a process first inferred from studies on insulin biosynthesis in the 1960s. In the late 1980s, the laboratory of Donald F. Steiner at the University of Chicago played a pivotal role in its identification. The enzyme was first purified and cloned from insulinoma cells and the bovine pituitary gland, with key contributions also from researchers at the Institut de pharmacologie moléculaire et cellulaire in France. Its homology to the yeast processing protease kexin and bacterial subtilisin established it as a member of a new eukaryotic protease family. Subsequent work in the 1990s, including the generation of *Pcsk1* knockout mice by researchers at the Jackson Laboratory, and the identification of human *PCSK1* mutations, solidified its critical role in endocrinology and metabolism.

Category:Proteases Category:Endocrinology Category:EC 3.4.21